Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs WOCKHARDT - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE WOCKHARDT CADILA HEALTHCARE/
WOCKHARDT
 
P/E (TTM) x 29.9 -92.8 - View Chart
P/BV x 4.8 2.1 234.2% View Chart
Dividend Yield % 0.7 0.0 38,220.3%  

Financials

 CADILA HEALTHCARE   WOCKHARDT
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
WOCKHARDT
Mar-18
CADILA HEALTHCARE/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs3521,012 34.8%   
Low Rs207532 38.9%   
Sales per share (Unadj.) Rs139.2355.9 39.1%  
Earnings per share (Unadj.) Rs11.8-60.3 -19.5%  
Cash flow per share (Unadj.) Rs18.6-46.8 -39.7%  
Dividends per share (Unadj.) Rs3.500.01 35,000.0%  
Dividend yield (eoy) %1.30 96,675.9%  
Book value per share (Unadj.) Rs101.4257.8 39.3%  
Shares outstanding (eoy) m1,023.74110.63 925.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.02.2 92.5%   
Avg P/E ratio x23.7-12.8 -185.5%  
P/CF ratio (eoy) x15.0-16.5 -91.2%  
Price / Book Value ratio x2.83.0 92.1%  
Dividend payout %29.80 -179,325.6%   
Avg Mkt Cap Rs m286,03385,379 335.0%   
No. of employees `00013.46.3 214.3%   
Total wages/salary Rs m24,1459,371 257.7%   
Avg. sales/employee Rs Th10,632.76,295.0 168.9%   
Avg. wages/employee Rs Th1,801.21,498.3 120.2%   
Avg. net profit/employee Rs Th898.5-1,066.3 -84.3%   
INCOME DATA
Net Sales Rs m142,53139,369 362.0%  
Other income Rs m1,1391,202 94.7%   
Total revenues Rs m143,67040,571 354.1%   
Gross profit Rs m24,19818 132,229.5%  
Depreciation Rs m6,9651,495 465.8%   
Interest Rs m3,4182,555 133.8%   
Profit before tax Rs m14,954-2,830 -528.5%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m3,198257 1,244.4%   
Profit after tax Rs m12,044-6,669 -180.6%  
Gross profit margin %17.00 36,523.6%  
Effective tax rate %21.4-9.1 -235.5%   
Net profit margin %8.5-16.9 -49.9%  
BALANCE SHEET DATA
Current assets Rs m87,15433,796 257.9%   
Current liabilities Rs m82,69426,917 307.2%   
Net working cap to sales %3.117.5 17.9%  
Current ratio x1.11.3 83.9%  
Inventory Days Days7179 90.0%  
Debtors Days Days9489 105.1%  
Net fixed assets Rs m133,23639,664 335.9%   
Share capital Rs m1,024553 185.1%   
"Free" reserves Rs m102,73327,968 367.3%   
Net worth Rs m103,75728,522 363.8%   
Long term debt Rs m32,14621,731 147.9%   
Total assets Rs m236,86681,620 290.2%  
Interest coverage x5.4-0.1 -4,999.2%   
Debt to equity ratio x0.30.8 40.7%  
Sales to assets ratio x0.60.5 124.8%   
Return on assets %6.5-5.0 -129.5%  
Return on equity %11.6-23.4 -49.6%  
Return on capital %13.7-7.7 -178.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m52,7529,807 537.9%   
Fx outflow Rs m14,5041,789 810.9%   
Net fx Rs m38,2488,019 477.0%   
CASH FLOW
From Operations Rs m25,054684 3,660.7%  
From Investments Rs m-10,1236,302 -160.6%  
From Financial Activity Rs m-10,942-7,695 142.2%  
Net Cashflow Rs m3,989-664 -600.8%  

Share Holding

Indian Promoters % 74.8 74.5 100.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 2.3 360.9%  
FIIs % 5.9 7.7 76.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 11.0 15.4 71.4%  
Shareholders   44,069 67,757 65.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 15, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS